Lol, no it certainly isn't the one to short. Even if someone were to think Exousia wouldn't make it as a company, as absurb a scenario as that sounds, the risk reward profile is very bad for a shortseller. We're looking at possbly $4+ dollars/share IF management delivers solid top line revenue growth in the area of $80M annualized by end of 2010. Read blindinvestors posts if you would like to see how we come to that valuation. Furthermore, the float is only 3.5 million shares tso in the event of good news, shorts could be crushed. Most stock is restricted so if insiders and insiders friends are holding for the ultimate payday (which I think they are), it means there's little stock to buyback and cover with.
1 member recommends this.
Chairman & CEO Wayne Rodrigue sheds light on Exousia's growth opportunities in Q3-Q4
